What are patient experiences with HDAC inhibitor treatment for T-cell lymphoma?
HDAC inhibitors are a class of targeted therapy that work by interfering with cancer cell DNA in a way that causes those cells to die. They are commonly used for T-cell lymphomas, particularly when the lymphoma has relapsed or stopped Show Full Answer
What are patient experiences with HDAC inhibitor treatment for T-cell lymphoma?
HDAC inhibitors are a class of targeted therapy that work by interfering with cancer cell DNA in a way that causes those cells to die. They are commonly used for T-cell lymphomas, particularly when the lymphoma has relapsed or stopped responding to other treatments.
The most frequently used HDAC inhibitors include:
- Vorinostat (Zolinza) — given intravenously
- Romidepsin (Istodax) — given intravenously
- Belinostat (Beleodaq) — another option in this drug class As for real-world experiences, a MyLymphomaTeam member shared about a family member's treatment with romidepsin, noting that after the first treatment session, the itching had subsided significantly and side effects were very mild.
Of course, everyone's experience can differ. It's always worth discussing potential side effects and what to expect with a care team before starting treatment. Keeping track of any changes — even small ones — can be really helpful during this process.
August 22
Join
Your Privacy Choices
